SG11201500584YA - Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate - Google Patents

Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate

Info

Publication number
SG11201500584YA
SG11201500584YA SG11201500584YA SG11201500584YA SG11201500584YA SG 11201500584Y A SG11201500584Y A SG 11201500584YA SG 11201500584Y A SG11201500584Y A SG 11201500584YA SG 11201500584Y A SG11201500584Y A SG 11201500584YA SG 11201500584Y A SG11201500584Y A SG 11201500584YA
Authority
SG
Singapore
Prior art keywords
irbesartan
atorvastatin
magnesium carbonate
tablet formulation
composite tablet
Prior art date
Application number
SG11201500584YA
Inventor
Yong Il Kim
Jung Hyun Cho
Jun Young Choi
Young Keun Choi
Jae Hyun Park
Jong Soo Woo
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50183917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201500584Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of SG11201500584YA publication Critical patent/SG11201500584YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11201500584YA 2012-08-31 2013-08-30 Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate SG11201500584YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120096477A KR20140028971A (en) 2012-08-31 2012-08-31 Bilayered tablet composite formulation of atorvastatin, irbesartan and magnesium carbonate
PCT/KR2013/007838 WO2014035188A1 (en) 2012-08-31 2013-08-30 Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate

Publications (1)

Publication Number Publication Date
SG11201500584YA true SG11201500584YA (en) 2015-02-27

Family

ID=50183917

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201500584YA SG11201500584YA (en) 2012-08-31 2013-08-30 Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate

Country Status (31)

Country Link
US (1) US20150209290A1 (en)
EP (1) EP2890368A4 (en)
JP (1) JP6363079B2 (en)
KR (1) KR20140028971A (en)
CN (1) CN104602677A (en)
AR (1) AR092386A1 (en)
AU (1) AU2013309686B2 (en)
BR (1) BR112015004471A8 (en)
CA (1) CA2882735A1 (en)
CL (1) CL2015000402A1 (en)
CR (1) CR20150115A (en)
DO (1) DOP2015000040A (en)
EA (1) EA030306B1 (en)
EC (1) ECSP15010600A (en)
GT (1) GT201500043A (en)
IL (1) IL237424A0 (en)
IN (1) IN2015DN01463A (en)
MA (1) MA37951B2 (en)
MX (1) MX354800B (en)
MY (1) MY175897A (en)
NI (1) NI201500027A (en)
NZ (1) NZ706472A (en)
PE (1) PE20150935A1 (en)
PH (1) PH12015500394A1 (en)
RU (1) RU2015111546A (en)
SG (1) SG11201500584YA (en)
TW (1) TWI651101B (en)
UA (1) UA115995C2 (en)
UY (1) UY35001A (en)
WO (1) WO2014035188A1 (en)
ZA (1) ZA201502156B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6981088B2 (en) * 2017-01-27 2021-12-15 ニプロ株式会社 Oral solid preparation
CR20190577A (en) * 2017-07-17 2020-01-29 Lilly Co Eli Pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
GT199800126A (en) * 1997-08-29 2000-01-29 COMBINATION THERAPY.
PE20030324A1 (en) 2001-07-31 2003-04-03 Warner Lambert Co PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN
AR060354A1 (en) * 2006-04-06 2008-06-11 Schering Corp THROMBIN RECEPTOR ANTAGONIST COMBINATION THERAPIES (TRA)
KR20090114325A (en) * 2008-04-29 2009-11-03 한올제약주식회사 Pharmaceutical formulation
JP5534004B2 (en) * 2010-03-29 2014-06-25 アステラス製薬株式会社 Orally disintegrating tablets
KR101248804B1 (en) * 2010-05-14 2013-03-29 한미사이언스 주식회사 BILAYERED PHARMACEUTICAL COMPOSITION OF HMG-CoA REDUCTASE INHIBITOR AND IRBESARTAN

Also Published As

Publication number Publication date
ECSP15010600A (en) 2015-12-31
AU2013309686B2 (en) 2017-09-07
AR092386A1 (en) 2015-04-22
CA2882735A1 (en) 2014-03-06
CR20150115A (en) 2015-04-16
MA37951A1 (en) 2018-06-29
JP6363079B2 (en) 2018-07-25
AU2013309686A1 (en) 2015-02-26
WO2014035188A1 (en) 2014-03-06
PH12015500394A1 (en) 2015-04-27
BR112015004471A8 (en) 2019-08-27
EA201590469A1 (en) 2015-06-30
IL237424A0 (en) 2015-04-30
UY35001A (en) 2014-03-31
KR20140028971A (en) 2014-03-10
JP2015530384A (en) 2015-10-15
GT201500043A (en) 2017-08-24
EA030306B1 (en) 2018-07-31
PE20150935A1 (en) 2015-06-20
BR112015004471A2 (en) 2017-07-04
NZ706472A (en) 2018-02-23
US20150209290A1 (en) 2015-07-30
MY175897A (en) 2020-07-14
EP2890368A1 (en) 2015-07-08
TW201414507A (en) 2014-04-16
UA115995C2 (en) 2018-01-25
ZA201502156B (en) 2016-07-27
MX2015002526A (en) 2015-06-23
CN104602677A (en) 2015-05-06
IN2015DN01463A (en) 2015-07-03
MX354800B (en) 2018-03-22
DOP2015000040A (en) 2015-04-15
TWI651101B (en) 2019-02-21
MA37951B2 (en) 2019-12-31
RU2015111546A (en) 2016-10-20
NI201500027A (en) 2017-01-04
EP2890368A4 (en) 2016-03-02
CL2015000402A1 (en) 2015-06-05

Similar Documents

Publication Publication Date Title
HK1205066A1 (en) Printer and tablet
HK1179953A1 (en) Pyrrolopyrimidine compounds and uses thereof
EP2599471A4 (en) Tablet splitting device
PL2469142T3 (en) Press fitting and its use
HK1208843A1 (en) Tablet press
GB2489658B (en) Tablet press
EP2877287A4 (en) Pill crushing system
EP2910918A4 (en) Pressure sensor, and sensor unit provided with same
EP2822931A4 (en) Triazolone compounds and uses thereof
IL223012B (en) Pharmaceutical formulation in the form of bilayered tablets comprising atorvastatin and irbesartan
EP2875014A4 (en) Anti-mucus drugs and uses therefor
EP2832534A4 (en) Combination apparatus of cold isostatic press and general press
ZA201405581B (en) Gastroretentive tablets
ZA201409508B (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
EP2857006A4 (en) Dry-coated tablet
ZA201502157B (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
PL2687083T3 (en) Baling press
ZA201502156B (en) Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate
HK1212680A1 (en) Triazolone compounds and uses thereof
EP2595609A4 (en) Coated effervescent tablet
IL229206A0 (en) Composition and tablet comprising raltegravir
SI2593081T1 (en) Ferrimannitol-ovalbumin tablet composition
HK1172424A1 (en) Architecture for providing on-demand and background processing
GB201214923D0 (en) Baling presses
HK1164045A2 (en) Tablet case